Effects of Infusion Timing on Treatment Response in Solid Tumors

NCT07630168 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

238

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Non-small Cell Lung Cancer
Metastatic Lung Cancer
Head and Neck Cancer
Metastatic Squamous Cell Carcinoma
Metastatic Head and Neck Cancer
Resectable Head and Neck Squamous-cell Carcinoma

Interventions

DRUG: PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM
DRUG: PD-1/PD-L1 inhibitor monotherapy - 4 cycles after 3 PM
DRUG: PD-1 inhibitor monotherapy - 2 cycles before 12:00PM
DRUG: PD-1 inhibitor monotherapy - 2 cycles after 3 PM

Sponsor

UNC Lineberger Comprehensive Cancer Center